Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details
- PMID: 33022187
- PMCID: PMC7874423
- DOI: 10.1164/rccm.202008-3333LE
Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details
Comment in
-
Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details.Am J Respir Crit Care Med. 2021 Jan 15;203(2):267-269. doi: 10.1164/rccm.202009-3605LE. Am J Respir Crit Care Med. 2021. PMID: 33022179 Free PMC article. No abstract available.
Comment on
-
Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.Am J Respir Crit Care Med. 2020 May 1;201(9):e56-e69. doi: 10.1164/rccm.202003-0625ST. Am J Respir Crit Care Med. 2020. PMID: 32283960 Free PMC article.
References
-
- Ekström M, Nilsson F, Abernethy AA, Currow DC. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease: a systematic review. Ann Am Thorac Soc. 2015;12:1079–1092. - PubMed
-
- Currow D, Louw S, McCloud P, Fazekas B, Plummer J, McDonald CF, et al. Australian National Palliative Care Clinical Studies Collaborative (PaCCSC) Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial. Thorax. 2020;75:50–56. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
